Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.54
-0.62 (-4.09%)
At close: Mar 5, 2026, 4:00 PM EST
14.30
-0.24 (-1.65%)
Pre-market: Mar 6, 2026, 7:08 AM EST
Eikon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.60
Upside
+76.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +99.45% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +133.84% | Mar 2, 2026 |
| Mizuho | Mizuho | Buy Initiates $26 | Buy | Initiates | $26 | +78.82% | Mar 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +120.08% | Mar 2, 2026 |
| Wedbush | Wedbush | Sell Initiates $7 | Sell | Initiates | $7 | -51.86% | Feb 26, 2026 |